Use of stating for the treatment of metabolic syndrome

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/404 (2006.01) A61K 31/47 (2006.01) A61P 3/06 (2006.01)

Patent

CA 2546793

The present invention relates to the use of a pharmaceutical composition consisting of a statin (especially fluvastatin or pitavastatin) or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier for the preparation of a medicament for the prevention or treatment of metabolic syndrome (or syndrome X).

L'invention concerne l'utilisation d'une composition pharmaceutique, formée d'une statine (notamment la fluvastatine ou la pitavastatine) ou d'un sel pharmaceutiquement acceptable de celle-ci et d'un excipient pharmaceutiquement acceptable, pour préparer un médicament destiné à prévenir ou à traiter le syndrome métabolique (ou syndrome X).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of stating for the treatment of metabolic syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of stating for the treatment of metabolic syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of stating for the treatment of metabolic syndrome will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1639557

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.